Closing Bell: Nervgen Pharma Corp down on Wednesday (NGEN)

Nervgen Pharma Corp opened trading today at $3.10 and closed at $2.86. It traded at a low of $2.80 to a high of $3.31.

The price eased -7.74 percent from the previous day's close of $3.10.

During the day across North America, the TSX Composite closed -0.45% at 21880.95, the S&P 500 closed -0.77% at 5199.50, the Dow Jones Industrial Average closed -0.60% at 38763.45 and the Nasdaq Composite closed 1.03% at 16366.85.

Nervgen Pharma Corp traded under NGEN on the Toronto Venture Exchange (TSX-V).

Trading volume was 314,376 on 589 total trades, with an average volume of 135,581 over the last 5 days.

The TSX-V market on the whole today saw 1,858 price advancers against 3,319 declines and 108 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, the shares have soared 71.26% in the last 52 weeks, while in 2024, they have raised 5.93%.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $216.78 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Nervgen Pharma Corp is holding an average recommendation of "Strong Sell" from 0.00 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..